These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25870586)

  • 1. The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes.
    Gillberg L; Ling C
    Front Endocrinol (Lausanne); 2015; 6():43. PubMed ID: 25870586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature aging of leukocyte DNA methylation is associated with type 2 diabetes prevalence.
    Toperoff G; Kark JD; Aran D; Nassar H; Ahmad WA; Sinnreich R; Azaiza D; Glaser B; Hellman A
    Clin Epigenetics; 2015; 7(1):35. PubMed ID: 25829970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and Type 2 Diabetes Risk.
    Dhawan S; Natarajan R
    Curr Diab Rep; 2019 Jun; 19(8):47. PubMed ID: 31250127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in the pathogenesis of type 2 diabetes in humans.
    Davegårdh C; García-Calzón S; Bacos K; Ling C
    Mol Metab; 2018 Aug; 14():12-25. PubMed ID: 29496428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.
    Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R
    Metabolism; 2014 Sep; 63(9):1188-97. PubMed ID: 24996265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.
    Nilsson E; Matte A; Perfilyev A; de Mello VD; Käkelä P; Pihlajamäki J; Ling C
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1491-501. PubMed ID: 26418287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel epigenetic determinants of type 2 diabetes in Mexican-American families.
    Kulkarni H; Kos MZ; Neary J; Dyer TD; Kent JW; Göring HH; Cole SA; Comuzzie AG; Almasy L; Mahaney MC; Curran JE; Blangero J; Carless MA
    Hum Mol Genet; 2015 Sep; 24(18):5330-44. PubMed ID: 26101197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.
    Willmer T; Johnson R; Louw J; Pheiffer C
    Front Endocrinol (Lausanne); 2018; 9():744. PubMed ID: 30564199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
    Raciti GA; Desiderio A; Longo M; Leone A; Zatterale F; Prevenzano I; Miele C; Napoli R; Beguinot F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications.
    Schrader S; Perfilyev A; Ahlqvist E; Groop L; Vaag A; Martinell M; García-Calzón S; Ling C
    Diabetes Care; 2022 Jul; 45(7):1621-1630. PubMed ID: 35607770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes.
    Nilsson E; Jansson PA; Perfilyev A; Volkov P; Pedersen M; Svensson MK; Poulsen P; Ribel-Madsen R; Pedersen NL; Almgren P; Fadista J; Rönn T; Klarlund Pedersen B; Scheele C; Vaag A; Ling C
    Diabetes; 2014 Sep; 63(9):2962-76. PubMed ID: 24812430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-resistance and depression cohort data mining to identify nutraceutical related DNA methylation biomarker for type 2 diabetes.
    Liang F; Quan Y; Wu A; Chen Y; Xu R; Zhu Y; Xiong J
    Genes Dis; 2021 Sep; 8(5):669-676. PubMed ID: 34291138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes.
    O'Connell TM; Markunas CA
    Curr Diabetes Rev; 2016; 12(1):20-9. PubMed ID: 25981498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation: a cause and consequence of type 2 diabetes.
    Kim M
    Genomics Inform; 2019 Dec; 17(4):e38. PubMed ID: 31896238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation in obesity and type 2 diabetes.
    de Mello VD; Pulkkinen L; Lalli M; Kolehmainen M; Pihlajamäki J; Uusitupa M
    Ann Med; 2014 May; 46(3):103-13. PubMed ID: 24779963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and developmental origins of diabetes: correlation or causation?
    Bansal A; Simmons RA
    Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E15-E28. PubMed ID: 29406781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
    Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
    Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality.
    Juvinao-Quintero DL; Hivert MF; Sharp GC; Relton CL; Elliott HR
    Curr Genet Med Rep; 2019 Dec; 7(4):191-207. PubMed ID: 32274260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional Factors, DNA Methylation, and Risk of Type 2 Diabetes and Obesity: Perspectives and Challenges.
    Parrillo L; Spinelli R; Nicolò A; Longo M; Mirra P; Raciti GA; Miele C; Beguinot F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.